Resmed Sustainability Profile
ResMed Inc., a leading player in the sleep and respiratory care industry, is headquartered in the United States, with significant operations across Europe, Asia, and Australia. Founded in 1989, ResMed has consistently innovated in the development of cloud-connected devices and software solutions that enhance patient care and improve quality of life for those with sleep apnoea and chronic obstructive pulmonary disease (COPD). The company’s core offerings include advanced continuous positive airway pressure (CPAP) devices, portable oxygen concentrators, and digital health solutions, all designed to provide seamless integration and user-friendly experiences. ResMed's commitment to research and development has positioned it as a market leader, recognised for its pioneering technologies and significant contributions to the field of sleep medicine. With a strong focus on improving patient outcomes, ResMed continues to set benchmarks in the healthcare industry.
DitchCarbon Score
How does Resmed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Resmed's score of 63 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Resmed's reported carbon emissions
In 2024, ResMed, headquartered in the United States, reported total carbon emissions of approximately 25,059,000 kg CO2e. This figure includes about 3,743,000 kg CO2e from Scope 1 emissions and about 21,317,000 kg CO2e from Scope 2 emissions. In comparison, the previous year, 2023, saw total emissions of about 28,391,000 kg CO2e, with Scope 1 at approximately 4,453,000 kg CO2e and Scope 2 at around 23,939,000 kg CO2e. This indicates a reduction in total emissions from 2023 to 2024. ResMed has set ambitious climate commitments, aiming to achieve net-zero greenhouse gas emissions across its value chain by FY2050, using FY2022 as the baseline year. The company has established near-term targets to reduce absolute Scope 1 and Scope 2 emissions by 42% by FY2030. Furthermore, long-term goals include a 90% reduction in Scope 1 and Scope 2 emissions by FY2050. For Scope 3 emissions, ResMed aims for a 51.6% reduction per megawatt (MW) constructed by FY2030 and a 97% reduction per MW by FY2050. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect ResMed's commitment to sustainable practices within the healthcare equipment sector. The company is actively working on initiatives to electrify its energy sources and develop site emissions profiles to further enhance its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is Resmed's Industry?
How Carbon Intensive is Resmed's Location?
Resmed's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Resmed has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Sysmed (China) Co. Ltd
Belluscura plc
Masimo
Frequently Asked Questions
Common questions about Resmed's sustainability data and climate commitments